Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Patients During a Blood Draw
NCT ID: NCT01846195
Last Updated: 2022-11-09
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2012-06-06
2013-03-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Volunteers During a Blood Draw
NCT01834612
Clinical Evaluation of the Zynex Blood Volume Monitor (CM-1500) in Healthy Male Adult Subjects During a Blood Draw
NCT01646060
Clinical Evaluation of the Zynex Monitoring System, Model CM-1600
NCT05740644
Evaluation of Physiological Variables and Detection of Blood Loss Using the Zynex Fluid Monitoring System, Model CM-1600
NCT05463198
Evaluation of Physiological Variables and Detection of Blood Loss in Healthy Adults With Different Subject Positioning by the CM-1500
NCT05980013
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
no blood draw
CM 1500 with no blood draw
CM 1500
blood draw
CM 1500 with blood draw
CM 1500
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CM 1500
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Between 18-35 years of age
* Weight between 130-200 pounds
Exclusion Criteria
* Recent caffeine intake
* Tobacco use in the (4) hours prior to screening
* Infection
* Pregnancy
* Hemoglobin \<13.5 g/dl
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
DTarget
UNKNOWN
Zynex Monitoring Solutions
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John Ziegler, MD
Role: PRINCIPAL_INVESTIGATOR
Premier Research Group plc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Premier Research Group
Salt Lake City, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Zynex500
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.